The Discounted Cash Flow (DCF) valuation of Zevra Therapeutics Inc (ZVRA) is (50.12) USD. With the latest stock price at 8.33 USD, the upside of Zevra Therapeutics Inc based on DCF is -701.7%.
Based on the latest price of 8.33 USD and our DCF valuation, Zevra Therapeutics Inc (ZVRA) is a sell. selling ZVRA stocks now will result in a potential gain of 701.7%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.3% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (106.71) - (33.44) | (50.12) |
| Upside | -1381.1% - -501.4% | -701.7% |